Best Stock Screener for Growth Investors: Tools Compared

The best stock screener for growth investors in 2026 is Finviz for US-only growth screens, and ScreenerHero for growth investors who also want reliable coverage of European and Canadian growth names in the same tool. Growth screening needs a different filter set than value screening — revenue growth trajectory and margin expansion matter more than any single valuation ratio — and most screeners built primarily around US large-cap growth names don't extend that same filter depth to Europe's smaller, less-covered growth companies.

Last updated: July 2026.

What growth investors need from a screener

Growth investing — buying businesses compounding revenue and earnings faster than the market, often at a valuation premium — needs filters that capture trajectory, not just a snapshot. The criteria that matter most:

Revenue growth (both trailing and multi-year CAGR): The primary growth signal. A single strong year can reflect a one-off; multi-year CAGR confirms the growth is sustained rather than a temporary spike.

Operating margin, and whether it's expanding: Growth without improving or stable margins is often just revenue being purchased with unsustainable spend. A screener that shows margin trend, not just the current figure, is materially more useful for growth screening.

ROIC: Confirms the growth is capital-efficient rather than requiring ever-larger reinvestment for diminishing returns. High ROIC alongside high revenue growth is the combination behind genuine compounders.

PEG ratio (P/E relative to growth rate): Growth stocks routinely trade at high absolute P/E ratios; PEG contextualises that premium against the growth rate actually being delivered, making cross-company comparison more meaningful than P/E alone.

EV/Sales: For earlier-stage or currently unprofitable growth companies where P/E is undefined, EV/Sales is the more usable valuation cross-check.

Rule of 40 (growth rate + margin): For software and recurring-revenue businesses specifically, Rule of 40 combines growth and profitability into a single screening signal — a filter almost no general-purpose screener exposes directly, but one that can be built from revenue growth and margin fields together.

The geographic dimension of growth investing

Growth screening content and tooling skews heavily toward US large-cap technology names — understandably, since the largest, most visible growth stories of the past decade have been US-listed. But genuine growth businesses exist across European and Canadian markets too, and they're systematically under-screened relative to their US counterparts:

• European software and tech (SAP, Temenos, Nordic SaaS names) trades at meaningfully lower growth multiples than comparable US peers for similar growth and margin profiles — see Rule of 40 screening for that specific comparison.
• German Mittelstand industrial technology and Nordic medtech frequently combine double-digit growth with strong ROIC, without the analyst coverage or retail attention that surfaces similar US names automatically.
• Canadian small-cap technology on the TSX and TSX Venture Exchange includes genuine growth companies that a US-only screener simply never surfaces.

A screener that only covers the Nasdaq and NYSE growth universe misses this entire adjacent opportunity set — not because it doesn't exist, but because most growth-focused screening tools were built US-first and never extended real filter depth to these markets.

Best screeners for growth investing compared

1. ScreenerHero — Best for global growth (US + Canada + Europe)

Growth filters available: Revenue growth (YoY and multi-year), operating margin (including trend), ROIC, PEG ratio, EV/Sales, gross margin. All filters work reliably across US, Canadian, and European markets, including small- and micro-cap names most screeners don't populate.

Geographic coverage: NYSE, NASDAQ, TSX and TSX Venture (Canada), XETRA (Germany), Euronext Paris (France), BME (Spain), Borsa Italiana (Italy), Nasdaq First North (Nordics), Euronext Growth Paris, AIM London, GPW (Warsaw), and more.

Small and microcap support: Yes — European and Canadian small-cap growth names are fully screenable with working revenue growth and margin filters, unlike most US-centric tools where this data is sparse or missing outside large caps.

Free tier: Full screener, no account required.

Paid plan: €29/month Pro.

Best for: Growth investors who screen globally, or who specifically want European and Canadian growth names alongside US ones in a single tool.

Limitations: No real-time data (EOD only) — a consideration for growth investors who also trade around earnings reactions intraday. No dedicated Rule of 40 field (must be built by combining revenue growth and margin filters).

2. Finviz — Best for US growth investing

Growth filters available: Revenue growth (quarterly and annual), EPS growth (multiple horizons), PEG ratio, gross/operating/net margin, ROIC, ROE. One of the deepest US-focused growth filter sets available, including forward estimate-based growth filters.

Geographic coverage: US only — NYSE, NASDAQ, NYSE American, OTC markets.

Free tier: Yes, no account required. Most fundamental growth filters available on the free tier.

Paid plan: $39.50/month Elite.

Best for: US-only growth investors. Finviz's estimate-based growth filters (forward EPS growth, analyst revision data) are a genuine differentiator for US large- and mid-cap growth screening specifically.

Limitations: No European or Canadian coverage — the adjacent growth opportunity set described above is simply inaccessible.

3. Stockopedia — Best for composite growth-quality scoring

Growth filters available: Revenue growth, EPS growth, margin trend. Stockopedia's StockRanks system also produces a composite Quality Rank and separate growth-oriented screens that combine growth with quality factors into a single score.

Geographic coverage: UK-weighted; continental European small-cap growth names have coverage gaps.

Free tier: None.

Paid plan: €60/month (EU + UK) · €80/month (US + EU + UK).

Best for: Growth investors who prefer a composite quality-growth score over building raw filter combinations themselves.

Limitations: Price is 2–2.7x ScreenerHero for narrower geographic coverage. Limited depth for continental European and Canadian growth names specifically.

4. TIKR — Best for growth trajectory research on a shortlist

Growth filters available: Revenue growth, EPS growth, margin trend, historical multi-year financial statement data going back up to 20 years on Pro — useful for confirming a growth trajectory is genuinely multi-year rather than recent.

Geographic coverage: Broad claimed coverage; European small-cap growth data is inconsistent for systematic bulk screening.

Free tier: Freemium with friction. Account required.

Paid plan: $40–55/month Pro.

Best for: Deep historical trajectory research on growth candidates already identified elsewhere — TIKR's long historical data window is genuinely useful for confirming growth consistency.

Not ideal for: Systematic bulk screening of European or Canadian growth candidates — data gaps make broad multi-market growth screening unreliable.

Comparison table

Bottom line

For US-only growth screening, Finviz's estimate-based filters remain the deepest available at the price. For growth investors who want European or Canadian growth names — including the small-cap software, industrial technology, and medtech companies that get systematically less attention than their US counterparts — screened with the same filter depth as US names, ScreenerHero is the more complete tool. Stockopedia and TIKR both serve narrower, complementary roles: composite quality-growth scoring and deep historical trajectory research on a shortlist, respectively.

Frequently asked questions

What's the best free stock screener for growth investing?

Both Finviz and ScreenerHero offer full growth-relevant filters (revenue growth, margins, PEG ratio) without requiring an account. Finviz has deeper US-specific growth filters, including forward estimate data; ScreenerHero adds working European and Canadian growth screening that Finviz doesn't cover.

What metrics matter most when screening for growth stocks?

Multi-year revenue growth (not just a single trailing year), margin trend (expanding, not just current level), ROIC, and PEG ratio to contextualise valuation against the growth rate. See revenue growth screening and operating margin screening for the detailed mechanics of the two most important individual filters.

Is there a good growth stock screener for European small caps?

Coverage is thinner than for US names across most tools. ScreenerHero specifically maintains working revenue growth and margin data for European small- and micro-cap growth names, including alternative markets like Euronext Growth and First North, where most US-centric growth screeners have no meaningful coverage.

Should growth investors use PEG ratio or just P/E?

PEG ratio is generally more useful for growth screening specifically, since it contextualises a high P/E against the growth rate actually being delivered — a stock with a 40x P/E and 40% growth has a very different risk profile than one with a 40x P/E and 10% growth, a distinction P/E alone doesn't capture.

Screen growth stocks across US, Canada, and Europe → — free, no account required. Filter by revenue growth, margin trend, ROIC, and PEG ratio across all major exchanges.